Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Olsson

Showing results (281-290 of 632) with videos related to

Pageof 64
Sort By:
Swedish Dental Journal|July 20, 2000
Treatment of class II furcation defects using resorbable and non-resorbable GTR barriersS Karapataki, H Falk, A Hugoso, et al.
Journal of the American College of Cardiology|June 1, 1985
Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidityG Olsson, N Rehnqvist, A Sjögren, et al.
British Heart Journal|August 1, 1972
Recent myocardial infarction and the conduction system. A clinico-pathological correlationL G Ekelund, A Moberg, A G Olsson, et al.
Atherosclerosis|November 1, 1971
Effects of oral calcium upon serum cholesterol and triglycerides in patients with hyperlipidemiaL A Carlson, A G Olsson, L Orö, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1975
Extraction of endogenous plasma triglycerides by the working human forearm muscle in the fasting stateA G Olsson, B Eklund, L Kaijser, et al.
Mutation Research|August 23, 2001
ELF magnetic field affects proliferation of SPD8/V79 Chinese hamster cells but does not interact with intrachromosomal recombinationG Olsson, I Y Belyaev, T Helleday, et al.
Postgraduate Medical Journal|January 1, 1975
Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemiaL Orö, A G Olsson, S Rössner, et al.
Acta Physiologica Scandinavica|October 2, 2002
Are early clinical effects of cholesterol lowering mediated through effects on inflammation?A G Olsson, G G Schwartz, L Jonasson, et al.
Lakartidningen|August 3, 1977
[Clinical experiences with prostaglandin E1 in severe peripheral artery disease]L A Carlson, T Jogestrand, L Kaijser, et al.
The American Journal of Cardiology|April 1, 1997
Overview of the safety of felodipine based on clinical trials in patients with hypertensionL Welin, L Elvelin, A Niklasson, et al.
Pageof 64

Showing results (281-290 of 632) with videos related to

Sort By:
Pageof 64
Swedish Dental Journal|July 20, 2000
Treatment of class II furcation defects using resorbable and non-resorbable GTR barriersS Karapataki, H Falk, A Hugoso, et al.
Journal of the American College of Cardiology|June 1, 1985
Long-term treatment with metoprolol after myocardial infarction: effect on 3 year mortality and morbidityG Olsson, N Rehnqvist, A Sjögren, et al.
British Heart Journal|August 1, 1972
Recent myocardial infarction and the conduction system. A clinico-pathological correlationL G Ekelund, A Moberg, A G Olsson, et al.
Atherosclerosis|November 1, 1971
Effects of oral calcium upon serum cholesterol and triglycerides in patients with hyperlipidemiaL A Carlson, A G Olsson, L Orö, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|May 1, 1975
Extraction of endogenous plasma triglycerides by the working human forearm muscle in the fasting stateA G Olsson, B Eklund, L Kaijser, et al.
Mutation Research|August 23, 2001
ELF magnetic field affects proliferation of SPD8/V79 Chinese hamster cells but does not interact with intrachromosomal recombinationG Olsson, I Y Belyaev, T Helleday, et al.
Postgraduate Medical Journal|January 1, 1975
Cholestyramine, clofibrate and nicotinic acid as single or combined treatment of type IIa and IIb hyperlipoproteinaemiaL Orö, A G Olsson, S Rössner, et al.
Acta Physiologica Scandinavica|October 2, 2002
Are early clinical effects of cholesterol lowering mediated through effects on inflammation?A G Olsson, G G Schwartz, L Jonasson, et al.
Lakartidningen|August 3, 1977
[Clinical experiences with prostaglandin E1 in severe peripheral artery disease]L A Carlson, T Jogestrand, L Kaijser, et al.
The American Journal of Cardiology|April 1, 1997
Overview of the safety of felodipine based on clinical trials in patients with hypertensionL Welin, L Elvelin, A Niklasson, et al.
Pageof 64